Announcements Trials

Browse Landscape

Status

Terminated 2 Unknown 1 Recruiting 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 7 Tumor-Agnostic 4 Gynecologic 3 Lymphoid 2 Head & Neck 2 Genitourinary 2 Thoracic 1 Sarcoma 1 Plasma cell 1 Other hematologic neoplasm 1 NET 1 Endocrine 1 CNS 1 Breast 1

Conditions

Breast Neoplasms 1

Interventions

Fulvestrant 78 pembrolizumab 77 Carboplatin 73 Capecitabine 69 Trastuzumab 66 Letrozole 62 Cyclophosphamide 61 Paclitaxel 60 Specimen Handling 52 pertuzumab 48 Docetaxel 48 abemaciclib 46 ribociclib 44 Anastrozole 35 130-nm albumin-bound paclitaxel 35 trastuzumab deruxtecan 34 Magnetic Resonance Spectroscopy 34 Tamoxifen 33 Blood Specimen Collection 33 sacituzumab govitecan 31 exemestane 31 Biopsy 31 Gemcitabine 30 Epirubicin 29 palbociclib 28 Surveys and Questionnaires 27 Injections 27 Drug Therapy 27 pyrotinib 26 eribulin 26

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Data Collection × Breast × Clear all

NCT02869607 2016-08-17

Institut Paoli Calmettes Breast Cancer Database

Institut Paoli-Calmettes

45,000 enrolled

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡